CLOSED
GET A PIECE OF MEDILOQ
Sustainable Child-Safe Packaging
Show more
REASONS TO INVEST
TEAM
Dan Estoque • CEO
Read More
Henry Burgess-Marshall • Director of Marketing
Read More
Nick Legare • Director of Sales
Read More
*Information from CNBC & Think Global Health (Source | Source)
**Information from PR Newswire & Business Wire (Source | Source)
the pitch
Plastic bans are beginning to take effect globally, as plastic pollution is becoming the largest public health threat (Source | Source). While plastic packaging is being phased out, the demand for sustainable packaging alternatives is growing. Mediloq offers manufacturers of pharma, supplement, cannabis, and household cleaner brands a sustainable alternative to single-use plastic through reusable child-safe packaging. Our vision is to integrate the company’s existing B2C retail brands with the new B2B sustainable packaging venture under a unified company vision. Our retail brands are targeted towards outdoor gear enthusiasts who value environmental stewardship, so the identity and purpose of both sides of the business will be aligned. Through this raise, we are looking to continue our mission of making a positive environmental impact by developing our B2B sustainable packaging business, while expanding our B2C product line and penetrating new markets.
Mediloq: Reusable, Refillable, Responsible
Plastic pollution is becoming the largest public health threat, and plastic bans are beginning to take effect globally (Source | Source). Just this year, 200 countries and the state of California have agreed to start phasing out disposable plastic packaging – with few sustainable alternatives available.
That's where Mediloq comes in! Since 2017, we have been selling our patented, ruggedized, sealed, child-safe containers to the outdoor, travel and tactical markets. With disposable plastic containers being phased out, there is a new B2B opportunity to leverage our patented, durable, child-safe design as a sustainable and reusable alternative to disposable plastic containers. We’re looking to scale up and develop next-gen, low-cost reusable designs and a reusable packaging model that offers pharma, supplement, cannabis, and household cleaner brands a sustainable alternative to single-use plastic child-safe packaging, and helps them meet their ESG goals.
We are already in discussions with several pharmaceutical companies who realize the benefits of our sustainable packaging model:
- Replacing plastic with eco-friendly packaging differentiates them from competitors.
- They need to explore alternative packaging strategies as plastics are phased out.
- Packaging costs of reusable containers are less than with single-use, throwaway containers.
Because consumers tend to choose convenience over sustainability, manufacturers are confident that governments will continue to encourage change by imposing levies on plastic products, which we believe will tilt the free market in our direction and drive consumers toward our reuse model. Manufacturers recognize that our closed-loop recycling model is a rapid-launch, relatively straightforward, and low-risk packaging alternative as it does not depend on breakthrough material technology or require extensive product testing. Our reuse model is based on the proven, returnable beverage bottle model – a well-understood system that was the standard for packaging before plastic was invented.
Our strategy is to integrate the company's new, B2B sustainable packaging venture with our existing revenue-generating B2C retail brands under a unified company vision. Our retail brands have always been targeted toward outdoor gear enthusiasts who value environmental stewardship, so the identity and purpose of both sides of the business will be aligned.
Through this raise, we are looking to continue our mission of making a positive environmental impact. We aim to achieve this by expanding into the B2B sustainable packaging business, while also using a portion of funds to grow revenue organically – through the expansion of our B2C product line, distribution channels, and penetrating new markets.
The Problem & Our Solution
Mediloq's Reusable Packaging Vision Helps Meet the Rising Demand for Sustainable Options
Approximately, 400 million tons of plastic waste is produced each year, and of that about 36% is used in packaging (Source). 91% of child-safe containers end up in landfills, which amounts to 1.4 billion pounds of waste (Source).
Plastic waste is polluting our water, food, and soil posing a serious public threat – by 2050 it is predicted that plastics will outweigh the fish in our oceans (Source | Source | Source).
And it's not just a litter problem, plastic is also a significant threat to the Earth's climate, and by 2050, the cumulation of greenhouse gas emissions from plastic could reach over 56 gigatons (Source).
Finally, world leaders are coming together to take action and have begun implementing bans on single-use plastic. The reduction in plastic as a packaging material is inevitable and it's coming, and manufacturers are just starting to plan for the coming supply shortage (Source | Source).
Sustainable packaging alternatives are high in demand, but most companies providing sustainable solutions are focused mainly on food and beverage packaging, which is simple and straightforward.
Conversely, reusable packaging for products requiring child-safe security has unique design challenges, because the child-safe mechanism has to be super-durable and remain child-safe over thousands of reuses, and it should be retested before each refill. Mediloq has a proven, patented solution to this obstacle, and to our knowledge, none of our competitors offer reusable child-safe packaging.
We are looking to expand into this unique B2B opportunity. Our vision is to reintroduce the beverage bottle reuse model, starting with the child-safe packaging niche, and eventually expanding to other types of consumer packaging.
Our B2B customers will be pharma, supplement, cannabis, and household cleaner brands, and child-safe packaging suppliers who are looking for sustainable alternatives to replace plastic.
In order to execute our B2B expansion, here are the steps we plan to take:
"The Highest-Quality Child-Safe Containers on the Planet"
Mediloq's patented, durable, child-safe design was originally developed for our line of high-end, ruggedized, sealed containers being marketed to the outdoor, recreational, and travel markets. Our retail brands are targeted toward customers who value top-quality gear that they can rely on under extreme conditions, and are willing to pay a premium price.
After we heard that customers were finding different applications for our retail products, we decided to develop dedicated brands to target these markets including Canniloq, Corloq, Coffeeloq, and Shotloq – all built around our patented, super-durable, sealed, twist-lock container. We believe, the revenue potential for B2C retail sales is huge and untapped, and we plan to expand the revenue-generating side of our business, including the licensing of patents to other product manufacturers.
In addition to our B2C retail revenue, our B2B initiatives have the potential to bring in three new streams of revenue.
First, we plan to sell our next-gen, low-cost containers to manufacturers who will fill and refill them through our program. Secondly, manufacturers will pay a small fee for the each container every time it is collected, sanitized, and tested before it is refilled. Finally, we hope to license our patents to child-safe product manufacturers and packaging suppliers for use in their own reusable systems.
The Market & Our Traction
Demand for Sustainable Packaging is On the Rise – Mediloq's Niche is Child-Safe Solutions
Mediloq offers product solutions in markets that are growing rapidly! In 2021, the Sustainable Packaging market was valued at $265.9 Billion and is estimated to grow at a CAGR of 5.10% between 2021 and 2028 (Source). Similarly, the global market for Sustainable Child-Safe Packaging was estimated at $19.3 Billion in 2020 and is estimated to reach $27.1 Billion by 2027, a CAGR of 5%.
With these growing markets, and the recent initiatives to ban plastics, it's clear to us that timing is our secret sauce. As plastic sourcing dwindles and sustainable alternatives become more of a norm, we believe we will benefit from the inevitable change coming for both consumers and manufacturers.
Our business model is protected by 2 relevant patent filings, and after generating significant e-commerce revenue, we recently signed an agreement with a firm that has a network of 20 sales reps who will sell our Canniloq brand into 2000+ B&M stores across the U.S.
We have also begun taking orders from an international defense products distributor to carry our Corloq tactical, outdoor branded products. They are proposing to submit our product to the DoD's Defense Logistics Agency Troop Support program as a field-grade, child-safe medication holder.
When it comes to our B2B plans, we are already in discussions with several potential pharmaceutical partners, and hope to have signed agreements within a few weeks. In addition, we’ve already been successful in getting dispensaries to market our first-gen durable child-safe containers as reusable alternatives to disposable plastic. This led us to receive an RFQ from a cannabis edible manufacturer for reusable child-safe containers, which have an estimated annual usage of 700k units a year.
Why Invest
Mediloq is on a Mission to Make a Positive Impact on our Environment While Disrupting the Market for Sustainable Packaging
We recognize significant ethical and business opportunities here. By leveraging our highly durable child-safe designs, IP, and ready-to-go technology – we believe we can help meet the growing demand for sustainable packaging, reduce global plastic pollution and set a good example for the future of consumer packaging.
Along with keeping up our revenue generating through B2C efforts, this raise will be used to develop next-gen sustainable child-safe packaging, automated wash & test equipment, as well as a kiosk collection system. This new capital will also be used to develop partnerships with customers, build a distribution network, and bolster our patent positions.
The tangible effects of climate change and an environmental crisis are being broadcast daily, and we believe investments in companies like ours give people the opportunity to take action. Join us on our mission, and invest in Mediloq!
ABOUT
HEADQUARTERS
5546 Spine Rd. Unit 104
Boulder, CO 80301
WEBSITE
View Site
TERMS
Mediloq
Overview
PRICE PER SHARE
$2.37
DEADLINE
Feb. 4, 2023 at 7:59 AM UTC
VALUATION
$5.99M
FUNDING GOAL
$15K - $581.2K
Breakdown
MIN INVESTMENT
$248.85
MAX INVESTMENT
$499,998.90
MIN NUMBER OF SHARES OFFERED
6,329
MAX NUMBER OF SHARES OFFERED
245,233
OFFERING TYPE
Equity
SHARES OFFERED
Class B Common Shares
Maximum Number of Shares Offered subject to adjustment for bonus shares
*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.
Investment Incentives & Bonuses*
Time-Based:
Friends, Family and Community Early Birds
Invest $250 within the first 48 hours and receive 20% bonus shares
Super Early Bird Bonus
Invest $250 within the first week and receive an 15% bonus shares
Early Bird Bonus
Invest $250 within the first 10 days and receive 10% bonus shares
Amount-Based:
$1,000+ | TIER 1 - $1,000
Invest $1,000+ and receive + 5% Bonus Shares.
$2,500+ | TIER 2 - $2,500
Invest $2,500+ and receive + 10% Bonus Shares.
$10,000+ | TIER 3 - $10,000
Invest $10,000+ and receive + 15% Bonus Shares.
$25,000+ | TIER 4 - $25,000
Invest $25,000+ and receive + 20% Bonus Shares.
*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus
Mediloq, Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Class B Common Stock at $2.37/ share, you will receive 110 shares of Class B Common Stock, meaning you'll own 110 shares for $237. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus in addition to the aforementioned bonus.
Irregular Use of Proceeds
ALL UPDATES
12.13.24
Mediloq Update Q3 2024
BOULDER, CO (December 10, 2024) – Mediloq announced today the appointment of Keenan Suacillo as Chief Executive Officer. Keenan brings extensive experience in go-to-market strategy, product management, and marketing across multiple industries. Keenan succeeds Dan Estoque, who will continue to serve as President and COO.
Throughout his career, Keenan has driven growth in SaaS, prop-tech, consumer packaged goods, nonprofit, and e-commerce sectors. His collaborative work with Operation Smile, Charlie Banana, BURST Oral Care, and other leading brands has yielded successful product launches and marketing campaigns in competitive markets.
Keenan earned his Bachelor of Business Administration in Management, Strategy, and Entrepreneurship from the University of Colorado at Boulder, building expertise in strategic management, organizational leadership, and market research. His academic foundation, combined with hands-on industry experience, provides a unique perspective on developing and scaling innovative solutions.
With extensive experience in consumer goods and regulated markets, combined with his deep knowledge of Mediloq's innovative push-and-twist reusable container system, Keenan will spearhead the company's strategic expansion into high-growth sectors including cannabis, outdoor recreation, healthcare, and consumer goods. His vision for Mediloq centers on elevating the industry through premium design and superior functionality, leveraging his proven track record of bringing premium products to demanding consumers and businesses.
"I'm honored to lead Mediloq," said Keenan Suacillo. "We're committed to delivering container solutions that meet modern security and sustainability demands. Together with our team and partners, we'll continue innovating to serve our markets effectively."
About Mediloq: Mediloq develops secure, reusable handheld container solutions for businesses and consumers across industries. Through thoughtful design and engineering, we're shaping the future of sustainable, secure handheld containers.
09.09.24
Mediloq Update Q2 2024
Dear Friends of Mediloq,
Here is a quick company update.
We at Mediloq are continuing our mission to offer sustainable alternatives to disposable plastic which is a contributor to the climate crisis.
The effects of climate change are becoming very apparent, and the increase in greenhouse gasses caused by plastic production and waste is being addressed by world governments.
In 2023, the UN facilitated a plastic treaty between 170 countries agreeing to phase out the use of single-use plastic packaging,
This is the key to our business model – as plastics are phased out as a packaging material, manufacturers will need sustainable alternatives to fill the huge demand, and Mediloq will be positioned as a solution.
We are continuing to use our retail revenue to survive until we can secure additional capital investment for our sustainable packaging venture:
- We are holding conversations with several candidates who have expressed an interest in joining the company in potential CEO or CMO roles. The strategic visions of these individuals vary: some want to focus on Mediloq’s sustainable packaging model - CaaS (Containers as a Service), others view scaling the existing retail brand verticals as low-hanging fruit. The expectation is that joining the company’s C-Suite will directly lead to additional investment capital.
- A few weeks ago we received a notification from the US Naval Research Lab that they wanted to purchase a Canniloq product from an online platform, and requesting that the necessary gov. forms be filled out in order for them to execute the transaction. The assumption is that these products are being evaluated as water-tight medication units or similar.
Best ways to help:
- Please do not hesitate to reach out if you can offer help
- Warm intros to retail and impact investors
- C-Suite and other key team members: If you know of any potential parties, we would love to speak with them
- Intros to supplement, pharma, packaging industry leaders
- Connections to CBD and outdoor retail channels
- Advice on growth: We are always looking for tactical advice on growth and partnership recommendations.
Best regards,
Mediloq Founders
06.11.24
Mediloq Update Q1 2024
Mediloq Update Q1 2024
Dear Friends of Mediloq,
Here is a quick company update.
We at Mediloq are continuing our mission to offer sustainable alternatives to disposable plastic which is a contributor to the climate crisis.
The effects of climate change are becoming very apparent, and the increase in greenhouse gasses caused by plastic production and waste is being addressed by world governments.
In 2023, the UN facilitated a plastic treaty between 170 countries agreeing to phase out the use of single-use plastic packaging,
This is the key to our business model – as plastics are phased out as a packaging material, manufacturers will need sustainable alternatives to fill the huge demand, and Mediloq will be positioned as a solution.
We are continuing to use our retail revenue to survive until we can secure additional capital investment for our sustainable packaging venture:
- We are continuing to explore a potential partnerships with an established company with our retail products. They have relationships with national distributors in several markets, which would enable us to introduce new products into different markets and scale our retail sales
- We continue to be persistent, seeking additional capital through VC’s, angels and family offices, but the process is very competitive. As more investors are affected by the climate crisis, momentum is building for sustainable startups, and we are hopeful that Mediloq will benefit.
In order for Mediloq to continue operations, until additional investment is found to fully launch our sustainable packaging business, we are relying on retail revenue:
- Our retail sales are 41% greater than this time last year, which is a result of adding 12 new SKU's to the Canniloq product line
- With the recent good news on Cannabis Rescheduling, we are focusing effort on positioning the Canniloq brand for potential growth/acquisition
- Our different retail platforms are being transitioned to Shopify, and we are exploring ways to improve SEO marketing
- We are looking for ways to resturcture the high-interest debt incurred during preparation for our 2 crowdfunding campaigns
Best ways to help:
- Please do not hesitate to reach out if you can offer help
- Warm intros to impact investors, leads for additional investment
- Board members, key team additions: If you know any great impact leaders, we would love to speak with them
- Intros to supplement, pharma, packaging industry leaders
- Connections to CBD and outdoor retail channels
- Advice on growth: We are always looking for tactical advice on growth and partnership recommendations.
What is Mediloq?
Mediloq’s mission is to reduce plastic pollution, greenhouse gasses and climate change by offering manufacturers of dietary supplements, OTC pharma and CBD products sustainable alternatives to plastic, child-safe packaging.
Best regards,
Mediloq Founders
02.17.24
Mediloq Update Q4 2023
Dear Friends of Mediloq,
Here is a quick company update.
We at Mediloq are continuing our mission to offer sustainable alternatives to disposable plastic which is a contributor to the climate crisis.
The effects of climate change are becoming very apparent, and the increase in greenhouse gasses caused by plastic production and waste is being addressed by world governments.
In 2023, the UN facilitated a plastic treaty between 170 countries agreeing to phase out the use of single-use plastic packaging,
This is the key to our business model – as plastics are phased out as a packaging material, manufacturers will need sustainable alternatives to fill the huge demand, and Mediloq will be positioned as a solution.
We are continuing to use our retail revenue to survive until we can secure additional capital investment for our sustainable packaging venture, but the outlook for 2024 is hopeful:
- We were approached by a company proposing a partnership which would include their new, proprietary coating to our products. They are currently in discussions with their investors about funding this new collaborative venture
- Several new individuals expressed an interest becoming key team members supporting our sustainable packaging venture. We are in discussions regarding potential roles as key team members and bringing in additional investment capital
- We started discussions with an established company about co-branding our retail products. They have relationships with national distributors in several markets, which would enable us to introduce new products into different markets and scale our retail sales
- We were invited and approved to list retail products on Walmart.ca
- We are exploring potential collaborators and funding sources associated with the University of Colorado
We continue to be persistent, seeking additional capital through VC’s, angels and family offices, but the process is very competitive. As more investors are affected by the climate crisis, momentum is building for sustainable startups, and we are hopeful that Mediloq will benefit.
In order for Mediloq to continue operations, until additional investment is found to fully launch our sustainable packaging business, we are relying on:
Retail Revenue:
We are expanding the marketing of our Canniloq and Corloq ruggedized child-safe brands through online commissioned affiliates, content creators and brand ambassadors.
IP:
Our patent portfolio is one of our main assets:
Containers: U.S. Utility Patent 10,518,939 - Durable, Child-Resistant Container With Seal Thrust Bearing
Refurbishing System: U.S. Utility Patent 11,731,176 - Refurbishing System For Reusable Child-Safe Containers
We plan to explore patent licensing opportunities as the reusable child-safe packaging market further develops.
Best ways to help:
- Please do not hesitate to reach out if you can offer help:
- Warm intros to impact investors, leads for additional investment
- Board members, key team additions: If you know any great impact leaders, we would love to speak with them
- Intros to supplement, pharma, packaging industry leaders
- Connections to CBD and outdoor retail channels
- Advice on growth: We are always looking for tactical advice on growth and partnership recommendations.
What is Mediloq?
Mediloq’s mission is to reduce plastic pollution, greenhouse gasses and climate change by offering manufacturers of dietary supplements, OTC pharma and CBD products sustainable alternatives to plastic, child-safe packaging.
Best regards,
Mediloq Founders
09.06.23
Mediloq Update 9-6-2023
Dear Friends of Mediloq,
Hope you are doing well, and here is a quick company update.
We at Mediloq are continuing our mission to offer sustainable alternatives to disposable plastic to help with the climate crisis.
The effects of climate change are becoming very apparent, and the increase in greenhouse gasses caused by plastic production and waste is starting to be addressed by world governments.
Two months ago in Paris, the world’s governments agreed to draft a new treaty to control plastics:
A first-of-its-kind ‘plastic treaty’ could end one of the world’s biggest sources of pollution
“The UN says it could cut production by a massive 80% by 2040”
This is the key to our business model – as plastics are phased out as a packaging material, manufacturers will need sustainable alternatives to fill the huge demand, and Mediloq will be positioned as a solution.
Fundraising Update:
In order to execute our sustainable packaging business venture, we require capital to sustain development and operations. The funds raised so far are as follows:
2022 - $37K raised on Ignite Social Impact crowdfunding platform
https://invest.ignitesocialimpact.com/offering/mloq/details
2023 - $20K raised on StartEngine crowdfunding platform
https://www.startengine.com/offering/mediloq
We continue to be persistent, seeking additional capital through VC’s, angels and family offices, but the process is very competitive. As more investors are affected by the climate crisis, momentum is building for sustainable startups, and we are hopeful that Mediloq will benefit.
In order for Mediloq to continue operations, until additional investment is found to fully launch our sustainable packaging business, we are relying on:
Retail Revenue:
We are expanding the marketing of our Canniloq and Corloq ruggedized child-safe brands through online commissioned affiliates, content creators and brand ambassadors.
IP:
We received notice on Aug. 8, 2023 that the US patent office granted our 2nd patent: U.S. Patent Application No. 16/831,412 Entitled, “REFURBISHING SYSTEM FOR REUSABLE CHILD-SAFE CONTAINERS”
We plan to explore patent licensing opportunities as the reusable child-safe packaging market further develops.
Best ways to help:
- Please do not hesitate to reach out if you can offer help:
- Warm intros to impact investors, leads for additional investment
- Board members, key team additions: If you know any great impact leaders, we would love to speak with them
- Intros to supplement, pharma, packaging industry leaders
- Connections to CBD and outdoor retail channels
- Advice on growth: We are always looking for tactical advice on growth and partnership recommendations.
What is Mediloq?
Mediloq’s mission is to reduce plastic pollution, greenhouse gasses and climate change by offering manufacturers of dietary supplements, OTC pharma and CBD products sustainable alternatives to plastic, child-safe packaging.
Best regards,
Mediloq Founders
01.30.23
Q1 & Q2 Road Map
Hi all, here is a summary of our business plans for the first half of 2023:
Retail Product Business
We will continue to grow revenue from our retail brands by focusing on marketing our existing product lines:
- Launching an affiliate marketing campaign of our Canniloq and Corloq brands - we plan to target 10 affiliate networks
- Signing content creators, influencers and brand ambassadors to drive sales from our affiliate network
- Create video and storyboard content for IG Reels, Youtube Shorts, TikTok, YouTube, Facebook
- Optimize our websites to improve SEO and sales flow
- Recruiting a commissioned sales team
- Expanding our product size and style options to fully launch our Coffeeloq brand
Sustainable Packaging Business
We will continue to seek capital to develop and launch our sustainable packaging venture by:
- Recruiting co-founders who have access to capital
- Applying to venture capital firms interested in making impact investments
- Seeking out private impact investors and angel groups
01.25.23
Invest in Mediloq and Reduce your 2022 Tax Bill
An investment in Mediloq's StartEngine Campaign through your IRA account can reduce your 2022 tax bill! The deadline to make an individual retirement account contribution that will decrease your 2022 tax bill, or even boost your refund, is the due date of your tax return, which for most people is April 18, 2023.
To use your IRA account to invest Mediloq's StartEngine Campaign:
- During the investment process, specify that you are investing as an entity, instead of as an individual, by checking the box labeled:
"I want to invest as a non-person legal entity such as a company, trust, or self-directed IRA". The box is located at the bottom of the "Contact Information" drop down. - You will then select the type of entity you will be investing as: IRA.
- For payments using IRAs, depending on how the IRA company sends funds, it will usually be wire or ACH.
You will need to request the wiring info from your IRA as they will be the vesting entity. The sent funds will be recorded as something like: Big IRA Company, Custodian for (or FBO), sometimes they add an account number.
See more info here
01.11.23
Mediloq in the News
Hi All,
Click the link below to read Dan Estoque's article in cannabis business trade publication, MJBizDaily, about how the cannabis packaging sector is leading the way out of the plastic packaging paradigm.
And in other news, after a competitive application process, Plastic Pollution Coalition member, Mediloq, is proud to be chosen as one of the recipients of a $400K grant awarded by the Colorado Enterprise Fund.
01.04.23
Reduce Plastics to Fight Climate Change
Hi All,
As we start 2023 with continued severe weather impacting the country, please do your part to fight climate change by making choices that have less harmful effects on the environment and influence positive change.
According to the Center for International Environmental Law, emissions from plastics in 2019 were equal to 198 coal plants, and it's projected that the plastics industry will release up to 1.34 billion tons of greenhouse gas emissions annually by 2030—about equal to the emissions of the entire continent of Africa today.
We at Mediloq are trying to do our part by offering sustainable alternatives to consumer plastic packaging. We know it's a small start, but our plan is to raise social awareness about the problem and solutions, building on the momentum of others committed to making a difference.
We are asking for concerned citizens to get involved, and ask for your financial investment in our company which will help help to make a positive impact for future generations.
Best regards,
Dan Estoque
Mediloq Founder & CEO
12.19.22
180% Increase in Amazon Retail Sales
We must be doing something right!
Despite U.S. shoppers pulling back on 2022 holiday spending, our units ordered on the Amazon platform are up 180% over this time last year!
Top Highlights from Amazon:
- 4.6 Star Reviews of our Canniloq branded containers
- We plan to fully launch our Corloq outdoor/survival brand on Amazon, capitalizing on Magpul's DAKA Can reliability issues
- Early 2023, we are introducing new colors in our Zytel Nylon series
- Mid 2023, we are launching a forged aluminum series which has a lower COGS than our legendary machined aluminum series
- We plan to re-activate our Amazon EU listings after the Covid pause
REWARDS
10%
Stack Venture Club & Rewards!
Members get an extra 10% shares in addition to rewards below!
Venture Club
Venture Club Members earn 10% bonus shares on top of this and all eligible investments for an entire year. Not a member? Sign up at checkout ($275/year).
$1,000
$1,000+ | TIER 1
Invest $1,000+ and receive + 5% Bonus Shares.
$2,500
$2,500+ | TIER 2
Invest $2,500+ and receive + 10% Bonus Shares.
$10,000
$10,000+ | TIER 3
Invest $10,000+ and receive + 15% Bonus Shares.
$25,000
$25,000+ | TIER 4
Invest $25,000+ and receive + 20% Bonus Shares.
JOIN THE DISCUSSION
0/2500
Ice breaker! What brought you to this investment?
HOW INVESTING WORKS
Cancel anytime before 48 hours before a rolling close or the offering end date.
WHY STARTENGINE?
REWARDS
We want you to succeed and get the most out of your money by offering rewards and memberships!
SECURE
Your info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTS
Invest in over 200 start-ups and collectibles!
FAQS
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000 are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, they are limited to investing 10% of the greater of the two amounts.
StartEngine makes it easy to invest using your retirement funds. You can open a self-directed IRA account through StartEngine. To get started, simply visit our IRA page for more information and step-by-step instructions.
Already have a self-directed IRA with another provider? You can still invest on StartEngine, but please note that the process will be manual and may take longer to complete.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancellation period. Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
